Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Viatris Inc.

VTRSNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$15.98
$0.06(0.38%)
U.S. Market opens in 15h 41m

Viatris Inc. Fundamental Analysis

Viatris Inc. (VTRS) shows weak financial fundamentals with a PE ratio of -5.01, profit margin of -26.13%, and ROE of -22.69%. The company generates $14.0B in annual revenue with weak year-over-year growth of -4.46%.

Key Strengths

PEG Ratio0.76

Areas of Concern

ROE-22.69%
Operating Margin-18.25%
We analyze VTRS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -27.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-27.6/100

We analyze VTRS's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTRS struggles to generate sufficient returns from assets.

ROA > 10%
-9.73%

Valuation Score

Excellent

VTRS trades at attractive valuation levels.

PE < 25
-5.01
PEG Ratio < 2
0.76

Growth Score

Weak

VTRS faces weak or negative growth trends.

Revenue Growth > 5%
-4.46%
EPS Growth > 10%
-12.62%

Financial Health Score

Excellent

VTRS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.97
Current Ratio > 1
1.35

Profitability Score

Weak

VTRS struggles to sustain strong margins.

ROE > 15%
-2268.99%
Net Margin ≥ 15%
-26.13%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VTRS Expensive or Cheap?

P/E Ratio

VTRS trades at -5.01 times earnings. This suggests potential undervaluation.

-5.01

PEG Ratio

When adjusting for growth, VTRS's PEG of 0.76 indicates potential undervaluation.

0.76

Price to Book

The market values Viatris Inc. at 1.21 times its book value. This may indicate undervaluation.

1.21

EV/EBITDA

Enterprise value stands at -7.59 times EBITDA. This is generally considered low.

-7.59

How Well Does VTRS Make Money?

Net Profit Margin

For every $100 in sales, Viatris Inc. keeps $-26.13 as profit after all expenses.

-26.13%

Operating Margin

Core operations generate -18.25 in profit for every $100 in revenue, before interest and taxes.

-18.25%

ROE

Management delivers $-22.69 in profit for every $100 of shareholder equity.

-22.69%

ROA

Viatris Inc. generates $-9.73 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.73%

Following the Money - Real Cash Generation

Operating Cash Flow

Viatris Inc. produces operating cash flow of $1.96B, showing steady but balanced cash generation.

$1.96B

Free Cash Flow

Viatris Inc. generates strong free cash flow of $1.58B, providing ample flexibility for dividends, buybacks, or growth.

$1.58B

FCF Per Share

Each share generates $1.37 in free cash annually.

$1.37

FCF Yield

VTRS converts 8.72% of its market value into free cash.

8.72%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.76

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.21

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.97

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.35

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.23

vs 25 benchmark

ROA

Return on assets percentage

-0.10

vs 25 benchmark

ROCE

Return on capital employed

-0.08

vs 25 benchmark

How VTRS Stacks Against Its Sector Peers

MetricVTRS ValueSector AveragePerformance
P/E Ratio-5.0129.43 Better (Cheaper)
ROE-22.69%800.00% Weak
Net Margin-26.13%-20145.00% (disorted) Weak
Debt/Equity0.970.30 Weak (High Leverage)
Current Ratio1.354.64 Neutral
ROA-9.73%-17936.00% (disorted) Weak

VTRS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Viatris Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-39.86%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-1871.56%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-40.08%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ